Paraoxonase 1 Mutations in a Turkish Population

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.

A. D. Watson, J A Berliner, Susan Hama et al. · Journal of Clinical Investigation · 1995 · 1.2K citations · Full text

Life Sciences, Biochemistry, Cell Biology +14

The molecular basis of the human serum paraoxonase activity polymorphism

Richard Humbert, David A. Adler, Christine M. Distèche et al. · Nature Genetics · 1993 · 840 citations

Life Sciences, Biochemistry, Genetics +4

Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes.

S. Adkins, K Gan, Maria Mody et al. · PubMed · 1993 · 485 citations

Life Sciences, Biochemistry, Molecular Genetics +6

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.

M C Garin, Richard W. James, Philippe Dussoix et al. · Journal of Clinical Investigation · 1997 · 478 citations · Full text

Medicine, Genetics, Molecular Genetics +11

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

Juan Carlos Ruiz, Alfredo Morabia, Hélène Blanché et al. · The Lancet · 1995 · 343 citations

Medicine, Cardiology, Genetics +14